Skip Ribbon Commands
Skip to main content
Menu

Publication List

2022

  1. Chua WM, Tang CYL, Tham WY, Yang SP, Tay YS, Loke KSH. Expect the Unexpected: Artifacts From Lodged 124I Capsule in Esophagus on PET/CT. Clin Nucl Med. 2022 Jun 1;47(6):547-548. doi: 10.1097/RLU.0000000000004046. Epub 2022 Jan 12. PMID: 35025804.
  2. Phua VJX, Yang CT, Xia B, Yan SX, Liu J, Aw SE, He T, Ng DCE. Nanomaterial Probes for Nuclear Imaging. Nanomaterials (Basel). 2022 Feb 9;12(4):582. doi: 10.3390/nano12040582. PMID: 35214911; PMCID: PMC8875160.
  3. Chua WM, Hoe KMJ, Dalan R, Too CW, Ong SYK, Tay TKY, Loke KSH. Anastomosing Hemangioma on 68Ga-DOTATATE PET/CT: A Potential Pitfall. Clin Nucl Med. 2022 Apr 1;47(4):321-323. doi: 10.1097/RLU.0000000000003984. PMID: 35020655.
  4. Puar TH, Khoo CM, Tan CJ, Tong AKT, Tan MCS, Teo AE, Ng KS, Wong KM, Reilhac A, O'Doherty J, Gomez-Sanchez CE, Kek PC, Yee S, Tan AWK, Chuah MB, Lee DHM, Wang KW, Zheng CQ, Shi L, Robins EG, Foo RSY; PA CURE investigators. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. J Hypertens. 2022 Jun 1;40(6):1179-1188. doi: 10.1097/HJH.0000000000003132. PMID: 35703880.
  5. Tan BF, Tan WCC, Wang FQ, Lechner M, Schartinger VH, Tan DSW, Loke KSH, Nei WL. PSMA PET Imaging and Therapy in Adenoid Cystic Carcinoma and Other Salivary Gland Cancers: A Systematic Review. Cancers (Basel). 2022 Jul 22;14(15):3585. doi: 10.3390/cancers14153585. PMID: 35892843; PMCID: PMC9330626.
  6. Yang CT, Ngam PI, Phua VJX, Yu SWK, Apoorva G, Ng DCE, Huang HL. Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast. Molecules. 2022 Nov 7;27(21):7646. doi: 10.3390/molecules27217646. PMID: 36364476; PMCID: PMC9656951.
  7. Chan SL, Chotipanich C, Choo SP, Kwang SW, Mo F, Worakitsitisatorn A, Tai D, Sundar R, Ng DCE, Loke KSH, Li L, Ng KKC, Peng YW, Yu SC. Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial. Liver Cancer. 2022 Jun 15;11(5):451-459. doi: 10.1159/000525489. PMID: 36158588; PMCID: PMC9485918.
  8. Soh BP, Lee SY, Wong WY, Pang BWJ, Lau LK, Jabbar KA, Seah WT, Chen KK, Srinivasan S, Ng TP, Wee SL. Body composition reference values in Singaporean adults using dual-energy X-ray absorptiometry-The Yishun study. PLoS One. 2022 Oct 21;17(10):e0276434. doi: 10.1371/journal.pone.0276434. PMID: 36269751; PMCID: PMC9586348.
  9. Sperry BW, Bateman TM, Akin EA, Bravo PE, Chen W, Dilsizian V, Hyafil F, Khor YM, Miller RJH, Slart RHJA, Slomka P, Verberne H, Miller EJ, Liu C. Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM. J Nucl Med. 2022 Jul 21:jnumed.122.264311. doi: 10.2967/jnumed.122.264311. Epub ahead of print. PMID: 35863895.
  10. He LM, Deng Y, Wang AB, Liu N, Chen Y, Yan XX, Zhang W. [Clinical Practice of 177Lu-DOTATATE in the Treatment of Neuroendocrine Tumors]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Dec;44(6):1102-1106. Chinese. doi: 10.3881/j.issn.1000-503X.14463. PMID: 36373637.

 

2021 

  1. Ghosh KK, Padmanabhan P, Yang CT, Wang Z, Palanivel M, Ng KC, Lu J, Carlstedt-Duke J, Halldin C, Gulyás B. An In Vivo Study of a Rat Fluid-Percussion-Induced Traumatic Brain Injury Model with [11C]PBR28 and [18F]flumazenil PET Imaging. Int J Mol Sci. 2021 Jan 19;22(2):951. doi: 10.3390/ijms22020951. PMID: 33477960; PMCID: PMC7835883.
  2. Levillain H, Bagni O, Deroose CM, Dieudonné A, Gnesin S, Grosser OS, Kappadath SC, Kennedy A, Kokabi N, Liu DM, Madoff DC, Mahvash A, Martinez de la Cuesta A, Ng DCE, Paprottka PM, Pettinato C, Rodríguez-Fraile M, Salem R, Sangro B, Strigari L, Sze DY, de Wit van der Veen BJ, Flamen P. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1570-1584. doi: 10.1007/s00259-020-05163-5. Epub 2021 Jan 12. PMID: 33433699; PMCID: PMC8113219.
  3. Kalimuddin S, Xie W, Watanabe S, Tham JY, Sam H, Chan KWK, Yap TS, Totman JJ, Chacko AM, Vasudevan SG, Low JG. 18F-fluorodeoxyglucose positron emission tomography as a window into human dengue pathophysiology. Antiviral Res. 2021 Jan;185:104991. doi: 10.1016/j.antiviral.2020.104991. Epub 2020 Dec 3. PMID: 33279522.
  4. Lechner M, Schartinger VH, Steele CD, Nei WL, Ooft ML, Schreiber LM, Pipinikas CP, Chung GT, Chan YY, Wu F, To KF, Tsang CM, Pearce W, Morelli D, Philpott M, Masterson L, Nibhani R, Wells G, Bell CG, Koller J, Delecluse S, Yip YL, Liu J, Forde CT, Forster MD, Jay A, Dudás J, Krapp A, Wan S, Uprimny C, Sprung S, Haybaeck J, Fenton TR, Chester K, Thirlwell C, Royle G, Marafioti T, Gupta R, Indrasari SR, Herdini C, Slim MAM, Indrawati I, Sutton L, Fles R, Tan B, Yeong J, Jain A, Han S, Wang H, Loke KSH, He W, Xu R, Jin H, Cheng Z, Howard D, Hwang PH, Le QT, Tay JK, West RB, Tsao SW, Meyer T, Riechelmann H, Oppermann U, Delecluse HJ, Willems SM, Chua MLK, Busson P, Lo KW, Wollmann G, Pillay N, Vanhaesebroeck B, Lund VJ. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy. Nat Commun. 2021 Jan 5;12(1):117. doi: 10.1038/s41467-020-20308-8. PMID: 33402692; PMCID: PMC7785735.
  5. Tang CYL, Chua WM, Cheng LTJ, Fong W, Zaheer S, Lam WW. 18F-FDG PET/CT Manifestations of IgG4-related Disease. Br J Radiol. 2021 Aug 1;94(1124):20210105. doi: 10.1259/bjr.20210105. Epub 2021 May 28. PMID: 34048289; PMCID: PMC8764915.
  6. Chew XH, Sultana R, Mathew EN, Ng DCE, Lo RHG, Toh HC, Tai D, Choo SP, Goh BKP, Yan SX, Loke KSH, Thang SP, Gogna A, Venkatanarasimha NK, Tong AKT, Moe FNN, Chua JSS, Ang RWT, Ong AD, Ng AWY, Hoang MTQ, Too CW, Thng CH, Chan WY, Kee W, Chan JHM, Irani F, Leong S, Lim KH, Wang MLC, Chow PKH. Real-World Data on Clinical Outcomes of Patients with Liver Cancer: A Prospective Validation of the National Cancer Centre Singapore Consensus Guidelines for the Management of Hepatocellular Carcinoma. Liver Cancer. 2021 Jun;10(3):224-239. doi: 10.1159/000514400. Epub 2021 Apr 7. PMID: 34239809; PMCID: PMC8237792.
  7. Huang HL, Chen RC, Teo I, Chaudhry I, Heng AL, Zhuang KD, Tan HK, Tan BS. A survey of anxiety and burnout in the radiology workforce of a tertiary hospital during the COVID-19 pandemic. J Med Imaging Radiat Oncol. 2021 Apr;65(2):139-145. doi: 10.1111/1754-9485.13152. Epub 2021 Feb 16. PMID: 33591604; PMCID: PMC8013876.
  8. Ghosh KK, Padmanabhan P, Yang CT, Ng DCE, Palanivel M, Mishra S, Halldin C, Gulyás B. Positron emission tomographic imaging in drug discovery. Drug Discov Today. 2022 Jan;27(1):280-291. doi: 10.1016/j.drudis.2021.07.025. Epub 2021 Jul 28. PMID: 34332093.
  9. Koo SX, Tong AK, Soh SY, Farid M, Loh A, Loke KS. Selective use of Peptide Receptor Radionuclide Therapy following comparative imaging of Ga-68 DOTATATE PET/CT against I-131 MIBG scintigraphy in a small Asian cohort of Adult Neuroblastoma. Med J Malaysia. 2021 Jul;76(4):573-577. PMID: 34305122.
  10. Leow MKS, Dogra S, Ge X, Chuah KL, Liew H, Loke KSH, McFarlane C. Paraneoplastic Secretion of Multiple Phosphatonins From a Deep Fibrous Histiocytoma Causing Oncogenic Osteomalacia. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2299-e2308. doi: 10.1210/clinem/dgaa964. PMID: 33462615; PMCID: PMC8063243.
  11. Huang HL, Ngam PI, Tan KM, Ng DCE, Lim ST, Chan JY. The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma. Ann Nucl Med. 2021 May;35(5):557-568. doi: 10.1007/s12149-021-01598-4. Epub 2021 Mar 8. PMID: 33683545.
  12. Ng DZ, Lee CY, Lam WW, Tong AK, Tan SH, Khoo LP, Tan YH, Chiang J, Chang EW, Chan JY, Poon EY, Somasundaram N, Farid H Rashid M, Tao M, Lim ST, Yang VS. Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method. Leuk Lymphoma. 2022 Jan;63(1):256-259. doi: 10.1080/10428194.2021.1992624. Epub 2021 Oct 19. PMID: 34665693.
  13. Yang SP, Koh LCW, Kong KW, Parameswaran R, Loke KSH, Ngiam KY, Tan WB, Loh T, Ng DCE, Goh BC, Ngeow J, Tai ES. A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients. Front Genet. 2021 Aug 25;12:721832. doi: 10.3389/fgene.2021.721832. PMID: 34512731; PMCID: PMC8425593.
  14. Tan SQ, Ngoh ASF, Ng WH, Xie WY, Krishnappa J, Sahul Hamed NB, Tang PH, Lim TCC, Chang KTE, Lee M, Kao MI-M, Low DCY, Chan DWS. Evaluation and outcomes of paediatric epilepsy surgery in Singapore: A single-centre audit. Neurology Asia. 2021; 26(3): 509-520. doi: https://doi.org/10.54029/2021zpd.
  15. Ngam PI, Ong CC, Tay EL, Hon JK, Liang C, Teo LL. Correlation of Aortic Valve Calcification Volume Using Cardiac-Gated Contrast-Enhanced CT with Aortic Stenosis Severity Using Echocardiographic Indices. Cardiovasc Imaging Asia. 2021 Jul;5(3):72-78. https://doi.org/10.22468/cvia.2021.00178.
  16. Tai D, Loke K, Gogna A, Kaya NA, Tan SH, Hennedige T, Ng D, Irani F, Lee J, Lim JQ, Too CW, Ng MCH, Tham CK, Lam J, Koo SL, Chong HS, Goh GB, Huang HL, Venkatanarasimha N, Lo R, Chow PKH, Goh BKP, Chung A, Toh HC, Thng CH, Lim TKH, Yeong J, Zhai W, Chan CY, Choo SP. Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):1025-1035. doi: 10.1016/S2468-1253(21)00305-8. Epub 2021 Oct 23. PMID: 34695377.
  17. Tong AKT, Ng DCE, Chow PKH. Internal Radiotherapy Using Radionuclides. In: Seong, J. (eds) Radiotherapy of Liver Cancer. Springer, Singapore. 2021 Jun. https://doi.org/10.1007/978-981-16-1815-4_10.
  18. Tang T, Martin P, Somasundaram N, Lim C, Tao M, Poon E, Yunon MJ, Toh SQ, Yan SX, Farid M, Chan JY, Lim ST. Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma. Haematologica. 2021 Dec 1;106(12):3170-3175. doi: 10.3324/haematol.2020.251454. PMID: 33147935; PMCID: PMC8634181.

 

2020 

  1. Appaduray SP, Khoo J, Somasundaram N, Chan J, Yan SX. Early Detection of Secondary Central Nervous System Lymphoma on PET/CT. Clin Nucl Med. 2020 May;45(5):e254-e257. doi: 10.1097/RLU.0000000000002991. PMID: 32149796.
  2. Lam WW, Loke KS, Wong WY, Ng DC. Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020? Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1645-1648. doi: 10.1007/s00259-020-04790-2. Epub 2020 Mar 30. PMID: 32232520; PMCID: PMC7105959.
  3. Khor YM, Cuddy S, Falk RH, Dorbala S. Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis. Semin Nucl Med. 2020 Jul;50(4):295-310. doi: 10.1053/j.semnuclmed.2020.01.001. Epub 2020 Feb 9. PMID: 32540027; PMCID: PMC9440475.
  4. Khor YM, Dorbala S. SPECT/CT quantification of lower limb perfusion: The next frontier in radionuclide perfusion imaging? J Nucl Cardiol. 2020 Dec;27(6):1934-1938. doi: 10.1007/s12350-019-02020-3. Epub 2020 Jan 14. PMID: 31939040.
  5. Tang CYL, Thang SP, Zaheer S, Kwan CK, Ng DC. Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian population. Endocrine. 2020 Jul;69(1):126-132. doi: 10.1007/s12020-020-02238-z. Epub 2020 Feb 28. PMID: 32112240.
  6. Sabiq S, Tham WY, Sinha AK, Loi HY. Lymphoma Recurrence Along the Lymphatic Tract on 18F-FDG PET/CT Presenting as Lower Limb Swelling. Clin Nucl Med. 2020 Feb;45(2):139-140. doi: 10.1097/RLU.0000000000002871. PMID: 31876814.
  7. Huang HL, Allie R, Gnanasegaran G, Bomanji J. COVID19 -Nuclear Medicine Departments, be prepared! Nucl Med Commun. 2020 Apr;41(4):297-299. doi: 10.1097/MNM.0000000000001183. PMID: 32168202; PMCID: PMC7144574.
  8. Gnanasegaran G, Huang HL, Williams J, Bomanji J. Coronavirus Pandemic: What Nuclear Medicine Departments Should Know. J Nucl Med Technol. 2020 Jun;48(2):89-97. doi: 10.2967/jnmt.120.247296. Epub 2020 Apr 20. PMID: 32312852; PMCID: PMC8679584.
  9. Lu Y, Yan SX, Lan X, Zhu X, Macapinlac HA. Nuclear medicine in responding to global pandemic COVID-19-American College of Nuclear Medicine member experience. Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1620-1622. doi: 10.1007/s00259-020-04799-7. PMID: 32296884; PMCID: PMC7158754.
  10. Loke KSH, Tham WY, Bharadwaj P, Keng FYJ, Huang Z, Idu MB, Wong YM, Tan PKS, Zaheer S, Khor YM, Ng DCE, Wong WY, Tong AK. Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT). J Nucl Cardiol. 2020 Jun;27(3):1005-1009. doi: 10.1007/s12350-020-02117-0. Epub 2020 Apr 19. PMID: 32306210; PMCID: PMC7166200.
  11. Ng KP, Wong B, Xie W, Kandiah N. Capgras Syndrome in the Young: Schizophrenia or Alzheimer Disease? Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):94-96. doi: 10.1097/WAD.0000000000000360. PMID: 31913960.
  12. Tham WY, Tong AKT, Loke KSH, Chio L, Lim GKY, Seah XY, Ng DCE, Yan SXX, Lam WWC. Divide and Conquer: Strategies in Singapore to Manage a Nuclear Medicine Department During COVID-19. J Nucl Med Technol. 2020 Jun;48(2):98-101. doi: 10.2967/jnmt.120.244855. Epub 2020 May 1. PMID: 32358044; PMCID: PMC8679583.
  13. Lu Y, Zhu X, Yan SX, Lan X. Emerging Attack and Management Strategies for Nuclear Medicine in Responding to COVID-19-ACNM Member Experience and Advice. Clin Nucl Med. 2020 Jul;45(7):534-535. doi: 10.1097/RLU.0000000000003077. PMID: 32404711; PMCID: PMC7268864.
  14. Sarah TB, Peiling Y, Loo TP, Ming WY, Yien LS, Soon TY, Loke KSH. Radiation exposure to allied health personnel handling blood specimens from patients receiving radioactive iodine-131 and recombinant human TSH (thyrogen®) stimulation. J Radiol Prot. 2020 May. doi: 10.1088/1361-6498/ab9507. PMID: 32434155.
  15. Thang SP, Lam WWC, Tong AKT, Allen JC Jr, Ler ASL, Tay YS, Somanesan S, Kanesvaran R, Wong ASC, Ng DCE. Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population. Nucl Med Commun. 2020 Jul;41(7):618-628. doi: 10.1097/MNM.0000000000001179. PMID: 32282629.
  16. Tay WL, Lee LMY, Tong AKT, Chng CL. Severe radiation thyroiditis after radioactive iodine for treatment of Graves' disease. Singapore Med J. 2021 Sep;62(9):486-491. doi: 10.11622/smedj.2020039. Epub 2020 Mar 31. PMID: 32227795; PMCID: PMC9251246.
  17. Yang CT, Hattiholi A, Selvan ST, Yan SX, Fang WW, Chandrasekharan P, Koteswaraiah P, Herold CJ, Gulyás B, Aw SE, He T, Ng DCE, Padmanabhan P. Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging. Acta Biomater. 2020 Jul 1;110:15-36. doi: 10.1016/j.actbio.2020.03.047. Epub 2020 Apr 23. PMID: 32335310.
  18. Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J. Nuclear medicine services after COVID-19: gearing up back to normality. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053. doi: 10.1007/s00259-020-04848-1. Erratum in: Eur J Nucl Med Mol Imaging. 2020 May 27;: PMID: 32367256; PMCID: PMC7197920.
  19. Cheng LTJ, Peh WM, Lam WWC. Safeguarding children from coronavirus disease 2019: Practices of nuclear medicine units in Singapore. Proceedings of Singapore Healthcare. 2020;30(1):36-40. doi:10.1177/2010105820930725.
  20. Xia B, Yan X, Fang W, Chen S, Jiang Z, Wang J, Sun Ti, Li Q, Li Z, Lu Y, He T, Cao B, Yang CT. Activatable Cell-Penetrating Peptide Conjugated Polymeric Nanoparticles with Gd-Chelation and Aggregation-Induced Emission for Bimodal MR and Fluorescence Imaging of Tumors. ACS Appl. Bio Mater. 2020, 3, 3, 1394–1405. https://doi.org/10.1021/acsabm.9b01049.
  21. Ferdinandus J, Violet J, Sandhu S, Hicks RJ, Ravi Kumar AS, Iravani A, Kong G, Akhurst T, Thang SP, Murphy DG, Williams S, Hofman MS. Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2322-2327. doi: 10.1007/s00259-020-04723-z. Epub 2020 Mar 5. PMID: 32140802.
  22. Violet J, Sandhu S, Iravani A, Ferdinandus J, Thang SP, Kong G, Kumar AR, Akhurst T, Pattison DA, Beaulieu A, Mooi J, Tran B, Guo C, Kalff V, Murphy DG, Jackson P, Eu P, Scalzo M, Williams S, Hicks RJ, Hofman MS. Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer. J Nucl Med. 2020 Jun;61(6):857-865. doi: 10.2967/jnumed.119.236414. Epub 2019 Nov 15. PMID: 31732676; PMCID: PMC7262220.
  23. Tang CYL, Lam WW, Tan PH, Xie W, Peh WM, Tan VK, Leong LCH. Myoepithelial hyperplasia: A rare mimic of breast cancer on 18 F-FDG PET/CT. Breast J. 2020 Apr;26(4):775-777. doi: 10.1111/tbj.13643. Epub 2019 Sep 28. PMID: 31562674.
  24. Ngam PI, Goh CX, Ng DC, Tan CJ, Osmany S, Tan AE, Kannivelu A, Cheng LT, Khor LK, Tong AK, Loke KS, Wong WY. COVID-19: Preparedness in Nuclear Medicine Departments in Singapore and Response to The Global Pandemic. Ann Acad Med Singap. 2020 Jul;49(7):496-500. PMID: 33000113.
  25. Sek KS, Tsang I, Lee XY, Albaqmi OH, Morosan Allo YJ, Rosmarin MC, Mahrous AK, Parameswaran R, Ng DCE, Tong AKT, Loke KSH, Brenta G, Alghamdi AH, Albati NA, Fish SA, Tuttle RM, Yang SP. Frequent neck US in papillary thyroid cancer likely detects non-actionable findings. Clin Endocrinol (Oxf). 2021 Mar;94(3):504-512. doi: 10.1111/cen.14325. Epub 2020 Sep 26. PMID: 32886805.
  26. Ghosh KK, Padmanabhan P, Yang CT, Mishra S, Halldin C, Gulyás B. Dealing with PET radiometabolites. EJNMMI Res. 2020 Sep 23;10(1):109. doi: 10.1186/s13550-020-00692-4. PMID: 32997213; PMCID: PMC7770856.
  27. Tong AK, Tham WY, Too CW, Tai DW, Chow PK, Ng DC. Molecular Imaging and Therapy of Liver Tumors. Semin Nucl Med. 2020 Sep;50(5):419-433. doi: 10.1053/j.semnuclmed.2020.04.004. Epub 2020 Jun 9. PMID: 32768006.
  28. Chandran M, Chin YA, Choo KS, Ang WC, Huang XF, Liu XM, Tay D, Aung TKK, Ali A, Thu WPP, Logan S, Yan SX, Lekamwasam S, Hao Y. Comparison of the Osteoporosis Self-Assessment Tool for Asians and the fracture risk assessment tool - FRAX to identify densitometric defined osteoporosis: A discriminatory value analysis in a multi-ethnic female population in Southeast Asia. Osteoporos Sarcopenia. 2020 Jun;6(2):53-58. doi: 10.1016/j.afos.2020.04.001. Epub 2020 Apr 26. PMID: 32715094; PMCID: PMC7374549.
  29. Tai WMD, Koo SL, Gogna A,  Tan SH, Ng DCE, Irani TPHF, Lee JJX, Too CW, Ng MCH, Tham CK, Lam JYC, Koo S-L, Chung A, Toh HC, Thng CH, Lim KH, Yeong JPS, Chan CY, Choo SP. A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678. Journal of Clinical Oncology. 2020 May; 38(15 Suppl):4590. doi: 10.1200/JCO.2020.38.15_suppl.4590. 

2019

  1. Huang HL, Tong AKT, Thang SP, Yan SX, Lam WWC, Loke KSH, Tang CYL, Cheng LTJ, Ooi GSK, Low HC, Magsombol BM, Tham WY, Goh CXY, Tan CJ, Khor YM, Zaheer S, Bharadwaj P, Xie W, Ng DCE. Current Status and Growth of Nuclear Theranostics in Singapore. Nucl Med Mol Imaging. 2019 Apr;53(2):96-101. doi: 10.1007/s13139-019-00580-3. Epub 2019 Jan 25. PMID: 31057680; PMCID: PMC6473098.
  2. Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 Sep;60(9):1234-1239. doi: 10.2967/jnumed.118.221770. Epub 2019 Apr 6. PMID: 30954943; PMCID: PMC6735282.
  3. Tan JSH, Goh CXY, Koh YS, Li Y, Tuan JKL, Chua ET, Tan TWK, Wang MLC, Lee LS, Tay KJ, Kanesvaran R, Toh CK, Tong AKT, Lam WWC, Chua MLK. 68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy. Cancer Biol Med. 2019 Feb;16(1):157-166. doi: 10.20892/j.issn.2095-3941.2018.0288. PMID: 31119056; PMCID: PMC6528443.
  4. Tai WM, Tan SH, Tan DMY, Loke KSH, Ng DCE, Yan SX, Hwang JSG, Lim KH, Loh LM, Kek PC, Goh BKP, Lee SY, Chung AYF, Ong SYK. Clinicopathologic Characteristics and Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasm in a Multi-Ethnic Asian Institution. Neuroendocrinology. 2019;108(4):265-277. doi: 10.1159/000495140. Epub 2018 Nov 6. PMID: 30399612.
  5. Osmany S, Zaheer S, Bartel TB, Johnston M, Peh WM, Barmaky S, Jadvar H. Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers. AJR Am J Roentgenol. 2019 Aug;213(2):286-299. doi: 10.2214/AJR.19.21084. Epub 2019 Jun 5. PMID: 31166760; PMCID: PMC7469486.
  6. Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Kumar AR, Thang SP, Eu P, Scalzo M, Murphy D, Williams S, Hicks RJ, Hofman MS. Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes. J Nucl Med. 2019 Apr;60(4):517-523. doi: 10.2967/jnumed.118.219352. Epub 2018 Oct 5. PMID: 30291192.
  7. Tang CYL, Lam WW, Tan PH, Xie W, Peh WM, Tan VK, Leong LCH. Myoepithelial hyperplasia: A rare mimic of breast cancer on 18 F-FDG PET/CT. Breast J. 2020 Apr;26(4):775-777. doi: 10.1111/tbj.13643. Epub 2019 Sep 28. PMID: 31562674.
  8. Thang SP, Violet J, Sandhu S, Iravani A, Akhurst T, Kong G, Ravi Kumar A, Murphy DG, Williams SG, Hicks RJ, Hofman MS. Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy. Eur Urol Oncol. 2019 Nov;2(6):670-676. doi: 10.1016/j.euo.2018.11.007. Epub 2018 Dec 13. PMID: 31412006.
  9. Violet J, Sandhu S, Iravani A, Ferdinandus J, Thang SP, Kong G, Kumar AR, Akhurst T, Pattison DA, Bearlieu A, Mooi J, Guo C, Kalff V, Murphy DG, Jackson P, Eu P, Scalzo M, Williams S, Hicks RJ, Hofman MS. Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer. Journal of Nuclear Medicine. 2019 Nov. doi: 10.2967/jnumed.119.236414.
  10. Cheng LTJ, Huang HL. Incidental pulmonary embolism detected on workup for Y-90 SIRT. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2621-2622. doi: 10.1007/s00259-019-04442-0. Epub 2019 Jul 31. PMID: 31367908.
  11. Suriyanto S, Ng EYK, Ng CED, Yan XS, Verma NK. 99mTc-MAG3 diuresis renography in differentiating renal obstruction: Using statistical parameters as new quantifiable indices. Comput Biol Med. 2019 Sep;112:103371. doi: 10.1016/j.compbiomed.2019.103371. Epub 2019 Jul 26. PMID: 31404720.
  12. Chandran M, Hao Y, Kwee AK, Swee DS, Ng DCE, Kee TYS, Bharadwaj P. Addressing bone quality and bone density after renal transplantation: A prospective evaluation of the evolution of trabecular bone score and bone mineral density over the first 5 years following renal transplantation in Asian patients. Clin Transplant. 2019 Oct;33(10):e13671. doi: 10.1111/ctr.13671. Epub 2019 Aug 16. PMID: 31332844.
  13. Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park MA, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H, Yee A, Sanchorawala V, Ruberg FL, Liao R, Berk J, Falk RH, Dorbala S. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1998-2009. doi: 10.1007/s00259-019-04627-7. Epub 2019 Dec 5. PMID: 31807884; PMCID: PMC8202062.

2018

  1. Nei W, Jain A, Wang F, Khor LK, Poh SYJ, Han S, Sommat K, Ang MK, Soong YL, Loke SHK. Somatostatin receptor imaging in nasopharyngeal cancer. 2018 Feb;2(2). doi: 10.21037/anpc.2018.0101.
  2. Thang SP, Lung MS, Kong G, Hofman MS, Callahan J, Michael M, Hicks RJ. Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis. Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):262-277. doi: 10.1007/s00259-017-3821-2. Epub 2017 Sep 12. Erratum in: Eur J Nucl Med Mol Imaging. 2017 Nov 20;: PMID: 28894897.
  3. Huang HL, Fong W, Peh WM, Niraj KA, Lam WW. The Utility of FDG PET/CT in IgG4-Related Disease with a Focus on Coronary Artery Involvement. Nucl Med Mol Imaging. 2018 Feb;52(1):53-61. doi: 10.1007/s13139-017-0494-5. Epub 2017 Sep 18. PMID: 29391913; PMCID: PMC5777961.
  4. Huang HL, Zhen Loh TJ, Hoe Chow PK. A Case of Well-differentiated Hepatocellular Carcinoma Identified on Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography. World J Nucl Med. 2018 Apr-Jun;17(2):102-105. doi: 10.4103/wjnm.WJNM_11_17. PMID: 29719484; PMCID: PMC5905253.
  5. Teo JY, Allen JC, Ng DCE, Abdul Latiff JB, Choo SP, Tai DW, Low ASC, Cheah FK, Chang JPE, Kam JH, Lee VTW, Chung AYF, Chan CY, Chow PKH, Goh BKP. Prospective study to determine early hypertrophy of the contra-lateral liver lobe after unilobar, Yttrium-90, selective internal radiation therapy in patients with hepatocellular carcinoma. Surgery. 2018 May;163(5):1008-1013. doi: 10.1016/j.surg.2017.10.014. Epub 2018 Jan 3. PMID: 29306542.
  6. Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Murphy DG, Eu P, Jackson P, Scalzo M, Williams SG, Sandhu S. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8. PMID: 29752180.
  7. Tham WY, Thian YL, Ratnagopal P, Xie W. 18F-FDG PET Brain in a Patient With Fatal Familial Insomnia. Clin Nucl Med. 2018 Aug;43(8):e274-e275. doi: 10.1097/RLU.0000000000002152. PMID: 29877883.
  8. Marchesseau S, Ng SA, Wang YT, Xie W, Ng DC, Totman JJ, Low AHL. 18F-FDG PET-MRI with T1 MOLLI mapping to detect systemic sclerosis bowel inflammation and fibrosis. Eur J Radiol. 2018 Aug;105:289-295. doi: 10.1016/j.ejrad.2018.06.022. Epub 2018 Jun 26. PMID: 30017295.
  9. Venkatanarasimha N, Gogna A, Muli Jogi R, Damodharan K, Chan SX, Ng DCE, Loke KSH, Irani FG, Lo RHG, Chandramohan S. Complications of 90Y Transarterial Radioembolization of Hepatic Tumors: Primer for Interventional Radiology Residents and Fellows RadioGraphics Fundamentals | Online Presentation. Radiographics. 2018 Jul-Aug;38(4):1282-1283. doi: 10.1148/rg.2018180062. PMID: 29995623.
  10. Marchesseau S, Ng SA, Wang YT, Xie W, Ng DC, Totman JJ, Low AHL. 18F-FDG PET-MRI with T1 MOLLI mapping to detect systemic sclerosis bowel inflammation and fibrosis. Eur J Radiol. 2018 Aug;105:289-295. doi: 10.1016/j.ejrad.2018.06.022. Epub 2018 Jun 26. PMID: 30017295.
  11. Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Kumar AR, Thang SP, Eu P, Scalzo M, Murphy D, Williams S, Hicks RJ, Hofman MS. Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes. J Nucl Med. 2019 Apr;60(4):517-523. doi: 10.2967/jnumed.118.219352. Epub 2018 Oct 5. PMID: 30291192.
  12. Yang CT, Ghosh KK, Padmanabhan P, Langer O, Liu J, Eng DNC, Halldin C, Gulyás B. PET-MR and SPECT-MR multimodality probes: Development and challenges. Theranostics. 2018 Nov 29;8(22):6210-6232. doi: 10.7150/thno.26610. PMID: 30613293; PMCID: PMC6299694.
  13. Ting SKS, Chen C, Hameed S, Ng A, Kandiah N, Prakash KM, Xie W, Lam WW, Sin GL, Chan LL, Rosa-Neto P, Gauthier S, Ng KP
    Phantom bedside intruder in Parkinson's disease. Neurology and Clinical Neuroscience. 2018 Nov. doi: 10.1111/ncn3.12258.
  14. Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D, Ang WC, Aung TKK, Choo KS, Ali A, Yan SX, Huang XF, Liu XM, Yong EL, Lekamwasam S. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos. 2018 Nov 19;13(1):130. doi: 10.1007/s11657-018-0542-5. PMID: 30456726.

SingHealth Updates for Healthcare Professionals

HealthXchange E-news Subscription

Health Buddy App

About Us
Patient Care
Education
Research
Careers
Giving
SingHealth
SingHealth Duke-NUS
Singapore General Hospital, Outram Road, Singapore 169608 +65 6222 3322

© 2024 SingHealth Group. All Rights Reserved.